🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/02/2020 34,81 35,60 33,64 35,36 -1,78% 5,63% 2.037.000
27/02/2020 35,07 37,80 34,40 36,00 -0,17% 9,69% 2.249.700
26/02/2020 34,24 37,00 34,01 36,06 +5,69% 8,73% 2.327.700
25/02/2020 37,00 37,57 33,99 34,12 -6,24% 9,68% 1.773.300
24/02/2020 37,00 38,10 35,73 36,39 -5,46% 6,41% 1.668.200
21/02/2020 39,68 39,76 37,80 38,49 -3,15% 4,94% 1.062.200
20/02/2020 39,90 40,25 38,11 39,74 -0,48% 5,36% 1.815.600
19/02/2020 40,99 41,88 39,89 39,93 -1,53% 4,86% 842.900
18/02/2020 40,50 41,24 39,93 40,55 -1,74% 3,23% 990.000
14/02/2020 40,59 41,57 40,49 41,27 +0,54% 2,66% 1.032.400
13/02/2020 42,17 42,41 40,98 41,05 -3,21% 3,39% 946.000
12/02/2020 41,80 42,81 41,34 42,41 +2,00% 3,52% 1.020.600
11/02/2020 43,25 43,69 41,05 41,58 -2,96% 6,10% 1.254.500
10/02/2020 40,35 43,30 39,61 42,85 +5,99% 9,14% 1.577.200
07/02/2020 40,86 41,14 40,05 40,43 -1,63% 2,67% 1.365.000
06/02/2020 46,01 46,42 40,15 41,10 -5,99% 13,63% 4.085.200
05/02/2020 44,80 45,25 42,95 43,72 -0,41% 5,14% 1.343.100
04/02/2020 44,20 45,09 43,72 43,90 +1,48% 3,09% 1.311.500
03/02/2020 42,36 44,69 42,25 43,26 +3,22% 5,76% 1.686.600
31/01/2020 41,27 42,50 40,90 41,91 +0,94% 3,88% 1.521.900
30/01/2020 43,74 44,33 41,06 41,52 -5,72% 7,48% 2.136.900
29/01/2020 45,20 45,95 43,85 44,04 -3,00% 4,65% 1.211.000
28/01/2020 44,41 45,66 44,23 45,40 +3,16% 3,22% 1.151.000
27/01/2020 43,05 44,80 42,39 44,01 -1,34% 5,60% 1.614.400
24/01/2020 46,34 47,31 43,64 44,61 -3,46% 7,92% 2.249.700
23/01/2020 47,22 47,71 46,19 46,21 -2,88% 3,22% 1.535.700
22/01/2020 47,59 49,34 47,41 47,58 -0,02% 4,06% 1.835.300
21/01/2020 52,35 52,75 46,48 47,59 -15,65% 11,98% 6.883.200
17/01/2020 57,69 57,69 56,11 56,42 -1,21% 2,74% 1.541.500
16/01/2020 57,12 57,98 56,75 57,11 +0,32% 2,15% 1.170.100